(AYTU) |
| 0 (0%) 05-29 22:43 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.63 |
| Resistance 1: | 2.38 |
| Pivot price: | 2.23 |
| Support 1: | 1.98 |
| Support 2: | 1.65 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -4.610 |
| Book Value | 3.270 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.417 |
| Profit Margin (%) | -60.17 |
| Operating Margin (%) | -32.74 |
| Return on Assets (ttm) | -3.7 |
| Return on Equity (ttm) | -97.4 |
Company news
Thu, 28 May 2026
AYTU: EXXUA’s launch drives growth as legacy ADHD revenues decline, with strong financial footing - TradingView
Tue, 19 May 2026
Earnings call transcript: Aytu BioPharma Q3 2026 reveals earnings miss - Investing.com
Mon, 18 May 2026
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 - ACCESS Newswire
Mon, 18 May 2026
Pharma firm Aytu BioPharma to present at virtual investor event May 28 - Stock Titan
Sat, 16 May 2026
Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long - simplywall.st
Thu, 14 May 2026
Aytu BioPharma Inc (AYTU) Q3 2026 Earnings Call Highlights: Stro - GuruFocus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
